Stockscreener 앱 받기
191.25
1.94%
3.64
전일 마감가:
$187.61
열려 있는:
$188.11
하루 거래량:
1.77M
Relative Volume:
1.83
시가총액:
$21.28B
수익:
$10.52B
순이익/손실:
$999.00M
주가수익비율:
22.87
EPS:
8.3628
순현금흐름:
$1.22B
1주 성능:
+2.30%
1개월 성능:
+3.58%
6개월 성능:
+12.18%
1년 성능:
+16.69%
1일 변동 폭
$187.80
$193.76
1주일 범위
$184.18
$193.76
52주 변동 폭
$148.70
$197.55
퀘스트 다이아그노스틱스 Stock (DGX) Company Profile
명칭
Quest Diagnostics Inc
전화
(973) 520-2700
주소
500 PLAZA DRIVE, SECAUCUS
DGX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
191.25 | 20.87B | 10.52B | 999.00M | 1.22B | 8.3628 |
|
TMO
Thermo Fisher Scientific Inc
|
587.48 | 215.18B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
227.39 | 156.94B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
725.91 | 55.05B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
151.25 | 41.12B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
224.90 | 36.97B | 15.90B | 1.28B | 2.21B | 7.2842 |
퀘스트 다이아그노스틱스 Stock (DGX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-25 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-04-02 | 개시 | Redburn Atlantic | Buy |
| 2025-03-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-01-06 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-12-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-10 | 재개 | Jefferies | Buy |
| 2024-10-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-08-28 | 재개 | Evercore ISI | In-line |
| 2024-07-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2023-12-12 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-06-29 | 개시 | Piper Sandler | Neutral |
| 2023-05-02 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-04-03 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-01-23 | 개시 | Evercore ISI | In-line |
| 2022-11-17 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-08-22 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-04-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-02-23 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-02-02 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-01-28 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2021-05-04 | 업그레이드 | UBS | Neutral → Buy |
| 2021-03-12 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-10-21 | 업그레이드 | Argus | Hold → Buy |
| 2020-07-29 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-14 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-06-09 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2020-06-02 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2020-04-28 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-27 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-04-27 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2020-03-27 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-08 | 개시 | Wells Fargo | Underweight |
| 2020-01-07 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2019-12-19 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-07-15 | 다운그레이드 | Goldman | Neutral → Sell |
| 2019-04-02 | 업그레이드 | Jefferies | Hold → Buy |
| 2019-03-18 | 재개 | Credit Suisse | Neutral |
| 2019-01-31 | 다운그레이드 | Argus | Buy → Hold |
| 2019-01-17 | 개시 | UBS | Neutral |
| 2019-01-03 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2018-11-30 | 다운그레이드 | Goldman | Buy → Neutral |
모두보기
퀘스트 다이아그노스틱스 주식(DGX)의 최신 뉴스
Is Quest Diagnostics Incorporated stock nearing a technical breakout2025 Analyst Calls & Technical Pattern Alert System - newser.com
Is Quest Diagnostics Incorporated (QDI) stock protected from inflationQuarterly Performance Summary & Expert Curated Trade Ideas - newser.com
How Quest Diagnostics Incorporated stock performs in rate cut cyclesQuarterly Portfolio Review & AI Driven Price Predictions - newser.com
Quest Diagnostics (DGX) Up 2.6% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Quest Diagnostics Stock Outlook: Is Wall Street Bullish or Bearish? - Yahoo Finance
How Quest Diagnostics Incorporated stock valuations compare to rivalsQuarterly Earnings Summary & Verified Stock Trade Ideas - newser.com
Can Quest Diagnostics Incorporated (QDI) stock deliver strong annual returnsChart Signals & Real-Time Chart Pattern Alerts - newser.com
How Quest Diagnostics Incorporated stock benefits from global expansionTake Profit & Expert Curated Trade Setup Alerts - newser.com
Is Quest Diagnostics Incorporated (QDI) stock good for long term investingPortfolio Growth Summary & Consistent Profit Focused Trading Strategies - newser.com
Will Quest Diagnostics Incorporated stock profit from fiscal stimulus2025 AllTime Highs & Detailed Earnings Play Alerts - newser.com
Published on: 2025-11-19 23:07:04 - newser.com
Using flow based indicators on Quest Diagnostics IncorporatedJuly 2025 Outlook & Safe Capital Preservation Plans - newser.com
What Fibonacci levels say about Quest Diagnostics Incorporated reboundIPO Watch & Weekly Top Stock Performers List - newser.com
Published on: 2025-11-19 13:33:19 - newser.com
Is Quest Diagnostics Incorporated (QDI) stock positioned for secular growthPrice Action & Advanced Swing Trade Entry Plans - newser.com
Why analysts maintain buy rating on Quest Diagnostics Incorporated stockJuly 2025 Setups & Verified Technical Signals - newser.com
Will Quest Diagnostics Incorporated stock gain from lower inflationJuly 2025 Review & Safe Capital Investment Plans - newser.com
Published on: 2025-11-19 01:41:12 - newser.com
Why Quest Diagnostics Incorporated stock is a strong buy callMarket Weekly Review & High Conviction Buy Zone Picks - newser.com
Published on: 2025-11-19 00:41:47 - newser.com
Why millennials buy Quest Diagnostics Incorporated stock2025 Technical Overview & Safe Capital Growth Stock Tips - newser.com
Published on: 2025-11-18 23:34:07 - newser.com
Will Quest Diagnostics Incorporated (QDI) stock beat international competition - newser.com
How Quest Diagnostics Incorporated stock trades before earningsJuly 2025 Technicals & Real-Time Volume Analysis Alerts - newser.com
Baird Adjusts Quest Diagnostics Price Target to $198 From $197, Maintains Neutral Rating - MarketScreener
퀘스트 다이아그노스틱스 (DGX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.59%
자본화:
|
볼륨(24시간):